Posted: 05 Mar 2010 05:58 PM PST
Biocon CMP: Rs. 262 Investment: 1 Year Target: Rs. 343 With 30 million diabetic patients in India, Biocon is well-placed to deliver good growth ahead with its insulin portfolio. In diabetology the company is growing at a rapid rate of 40 per cent in the domestic segment. The company enjoys a market share of 12 per cent in the [...]
Posted: 05 Mar 2010 05:45 PM PST
|You are subscribed to email updates from Stock Market India Bonus Issues, Stock Splits, Right Issues and Market News |
To stop receiving these emails, you may unsubscribe now.
|Email delivery powered by Google|
|Google Inc., 20 West Kinzie, Chicago IL USA 60610|